Skip to main content
. 2010 Oct 20;60(1):99–109. doi: 10.1007/s00262-010-0923-0

Fig. 2.

Fig. 2

Antitumor effect of MVA-survivin vaccine. C57BL/6 mice received s.c. injections of 2.5 × 105 Pan02 cells on day 0. When the tumors were palpable and reached 3–4 mm in diameter, mice were immunized i.p. with 5 × 107 pfu of MVA-survivin. Booster immunization was performed 7 days after the prime immunization. Tumors were measured twice weekly in three dimensions with calipers. Bars represent SE